Our rationale for identifying CSP, AMA1 and TRAP epitopes is to construct a multi-epitope malaria vaccine designed to induce long-lasting protective CD8+ T cell responses that may be superior to current antibody-based vaccines, or to supplement these vaccines. This evidence concerns the gene CD8A and malaria.